Luminex Corporation

(LMNX) Trade

By |

Profile

Luminex Corp is a biotechnology company that develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. The company primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex's market segments mainly include infectious disease, genetic or inherited disease, personalized medicine, and life sciences research. It offers various solutions in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. The vast majority of the company's revenue is earned in the United States.

Contact Information

Website: www.luminexcorp.com
Email: hcurrie@luminexcorp.com
Main Phone: +1 512 219-8020
Address: 12212 Technology Boulevard
Address 2: Suite 130
State: TX
City / Town: Austin
Country: US
Postal Code: 78727

Issuer Information

Exchange: NGS
CEO: Nachum Shamir
Employees: 1247
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

Profile

Luminex Corp is a biotechnology company that develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. The company primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex's market segments mainly include infectious disease, genetic or inherited disease, personalized medicine, and life sciences research. It offers various solutions in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. The vast majority of the company's revenue is earned in the United States.

Contact Information

Website: www.luminexcorp.com
Email: hcurrie@luminexcorp.com
Main Phone: +1 512 219-8020
Address: 12212 Technology Boulevard
Address 2: Suite 130
State: TX
City / Town: Austin
Country: US
Postal Code: 78727

Issuer Information

Exchange: NGS
CEO: Nachum Shamir
Employees: 1247
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

$ 24.59 $ 0.31 (1.28%)
Last Price 24.59 Change $ 0.31 Change % 1.28 Tick N/A
Bid 14.50 Bid Size 300.00 Ask 26.70 Ask Size 1,000.00
Open 24.33 High 24.81 Low 24.20 Prev Close 24.28
Last Trade Volume 550,168 52 Wk Hi 41.69 52 Wk Low 20.30
Market Cap 1.1 bi Ex-Div Date Div Rate 0.36 Yield 1.5520
Shares 46,525,493.00 EPS (TTM) 0.39 PE Ratio 62.30 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 40
Number of Buys 2 9
Number of Sells 3 31
Net Activity -36962 -161607
Last 10 Buys Shares
Harriss T. Currie 1,000
Richard W Rew 1,000
Nachum Shamir 1,000
Walter Loewenbaum 1,000
Nachum Shamir 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Last 10 Sell Shares
Walter Loewenbaum 1,000
Todd C. Bennett 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Walter Loewenbaum 1,000
Robert J. Cresci 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 24 24 24 24
Low Target Price Estimate 19 19 19 19
Mean Target Price Estimate 21.6 21.6 21.6 21.6
Standard Deviation 1.82 1.82 1.82 1.82
Date of Most Recent Estimate 05/08/18 05/08/18 05/08/18 05/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 5 5 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1
Mean Rec. 2.67 2.67 3 3